|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
|
Medirom Healthcare Technologies Inc. (Name of Issuer) |
American depositary shares, each representing one common share, no par value (Title of Class of Securities) |
(CUSIP Number) |
Jun Kanma c/o Kufu Company Holdings, Inc., Mita Ko, 1-4-28 Mita Minato-ku Tokyo, M0, 108-0073 (813)6435-1687 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
07/14/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Kufu Company Holdings, Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
JAPAN
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
American depositary shares, each representing one common share, no par value | |
| (b) | Name of Issuer:
Medirom Healthcare Technologies Inc. | |
| (c) | Address of Issuer's Principal Executive Offices:
16F Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo,
JAPAN
, 135-0091. | |
Item 1 Comment:
SCHEDULE 13D - EXPLANATORY NOTE
This Amendment No. 3 (this "Amendment No. 3") to statement on Schedule 13D, which was initially filed on January 6, 2023 and amended on May 30, 2025 and March 30, 2026 (as amended, the "Schedule 13D"), relates to the American depositary shares ("ADSs") of MEDIROM Healthcare Technologies Inc., a joint stock corporation with limited liability organized under the laws of Japan (the "Issuer"), whose principal executive offices are located at 16F Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo 135-0091.
Each ADS represents one common share, no par value, of the Issuer (the "Common Shares").
This Amendment No. 3 amends and supplements the Schedule 13D to report that the Reporting Person is no longer the beneficial owner of any Common Shares. The filing of this Amendment No. 3 represents the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Person.
Except as set forth herein, all Items of the Schedule 13D remain unchanged. | ||
| Item 4. | Purpose of Transaction | |
Item 4 of the Schedule 13D is amended and supplemented to add the following:
On July 14, 2026, the Bonds previously held by the Reporting Person were redeemed in full. As a result, the Reporting Person no longer beneficially owns any Common Shares. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The information contained in rows 7, 8, 9, 10, 11, 12 and 13 on the cover page of this Schedule 13D and in the footnotes thereto is incorporated herein by reference. | |
| (b) | The information contained in rows 7, 8, 9, 10, 11, 12 and 13 on the cover page of this Schedule 13D and in the footnotes thereto is incorporated herein by reference. | |
| (c) | The information in Items 3 and 4 of this Schedule 13D is incorporated herein by reference. The Reporting Person has not engaged in any transaction in ADSs in the 60 days prior to the filing of this Schedule 13D other than as described in Item 4. | |
| (d) | None. | |
| (e) | Not applicable. | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|